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Abstract
Purpose
Proton magnetic resonance spectroscopy (1H MRS) is a noninvasive neuroimaging method
to quantify biochemical metabolites in vivo and it can serve as a powerful tool to monitor
neurobiochemical profiles in the brain. Asperger’s syndrome (AS) is a type of autism spec-
trum disorder, which is characterized by impaired social skills and restrictive, repetitive pat-
terns of interest and activities, while intellectual levels and language skills are relatively
preserved. Despite clinical aspects have been well-characterized, neurometabolic profiling
in the brain of AS remains to be clear. The present study used proton magnetic resonance
spectroscopy (1H MRS) to investigate whether pediatric AS is associated with measurable
neurometabolic abnormalities that can contribute new information on the neurobiological
underpinnings of the disorder.
Methods
Study participants consisted of 34 children with AS (2–12 years old; mean age 5.2 (±2.0); 28
boys) and 19 typically developed children (2–11 years old; mean age 5.6 (±2.6); 12 boys)
who served as the normal control group. The 1H MRS data were obtained from two regions
of interest: the anterior cingulate cortex (ACC) and left cerebellum.
Results
In the ACC, levels of N-acetylaspartate (NAA), total creatine (tCr), total choline-containing
compounds (tCho) and myo-Inositol (mI) were significantly decreased in children with AS
compared to controls. On the other hand, no significant group differences in any of the
metabolites were found in the left cerebellum. Neither age nor sex accounted for the meta-
bolic findings in the regions.
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Conclusion
The finding of decreased levels of NAA, tCr, tCho, and mI in the ACC but not in left cerebel-
lar voxels in the AS, suggests a lower ACC neuronal density in the present AS cohort com-
pared to controls.
Introduction
Asperger’s syndrome (AS) is a brain disorder characterized by impaired social skills and non-
verbal communication, as well as restrictive and repetitive patterns of behavior and activities
[1]. Although AS has been reclassified as an autistic spectrum disorder (ASD) in the 5th edition
of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) [2], there have been
suggestions that AS and ASD can present with distinct verbal styles, motor signs, emotion per-
ception, and pragmatic reasoning [3].
Pathophysiologically, a number of limbic and cortical structures are believed to be impli-
cated in AS/ASD [4]. Due to the ritualistic behavior and impaired social interactions in AS/
ASD, a great deal of attention has been focused on the anterior cingulate cortex (ACC), as the
structure in the limbic system involved in response inhibition, in delineating between the per-
ception of self and others, as well as in error detection, all of which are impaired in AS/ASD
[5]. Further implicating the ACC are the results of task-related functional magnetic resonance
imaging (fMRI) studies, which have consistently found ACC hypoactivation in ASD [6–9].
In the present study, we sought to advance our understanding of the neurobiological under-
pinnings of AS by using proton magnetic resonance spectroscopy (1H MRS), a noninvasive
neuroimaging technique that enables in vivo examination of brain metabolism and chemistry,
to investigate potential neurometabolic abnormalities in the ACC and cerebellum of children
with AS.
Several prior 1H MRS studies in ASD [10,11], and three in AS have been reported [12–14].
A meta-analysis of 1H MRS data from the ACC of children with ASD found significant
decreases in the levels of the putative neuronal marker, N-acetylaspartate (NAA), compared to
controls [10]. By contrast, levels of frontal lobe NAA were found to be higher in AS than in
controls in the two prior studies [12,13]. Despite these discrepant NAA findings in ASD and
AS, we hypothesized that, as in the two prior studies in AS, NAA would be increased in the dis-
order compared to controls, while no differences would be observed in the cerebellum. In sec-
ondary analyses, levels of total creatine (tCr), total choline (tCho), myo-inositol (mI),
combined glutamate and glutamine–referred to as Glx–and γ-aminobutyric acid (GABA)
were compared between the groups.
Methods
Participants
For this study, which was approved by the Institutional Review Board of Tokushima Univer-
sity, 34 children (2–12 years old; mean age: 5.2 ± 2.0; 28 boys) diagnosed with AS according
DSM-IV-TR criteria [1], were recruited from among the outpatients of the Department of
Pediatrics. To participate in the study, each child’s parent or legal guardian provided written
informed consent according to the principles of Declaration of Helsinki. Children old enough
to understand the content and purpose of the study also provided their assent.
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Nineteen children (2–11 years old; mean age: 5.6 ± 2.6; 12 boys) referred for MRI examina-
tion due to a non-specific temporal symptom (e.g., headache or vertigo), but were otherwise
healthy, were recruited to serve as the normal comparison group (Table 1). To minimize anxi-
ety and motion, all participants were sedated with 0.5ml/kg body weight of triclofos sodium,
which was administered approximately one hour before the MRI scan and monitored accord-
ing to the sedation guidelines of the American Academy of Pediatrics [15]. We first examined
1H MRS in the ACC followed by the left cerebellum. For children who could not lie still we
only measured 1H MRS in the ACC.
1H MRS measurement
All neuroimaging studies were conducted on a General Electric 3.0 T Signa HD MRI system
(Milwaukee, WI, USA) with a standard volume birdcage radiofrequency head coil.
To acquire the brain 1H MRS data, two methods were implemented. First, conventional
short echo time (TE) spectra were obtained using the Stimulated Echo Acquisition Mode
(STEAM) sequence with repetition time (TR) = 5000 ms, echo time (TE) = 15 ms and 48 signal
averages to record spectra from a 1.5×2.0×2.0-cm3 voxel prescribed in the ACC and in the left
cerebellum (Fig 1). Next, without moving the subjects spectra were again obtained from a
3x3x3-cm3 voxel, but using the standard Point RESolved Spectroscopy (PRESS) sequence,
which had been modified to enable the detection of γ-aminobutyric acid (GABA) by J-edited
spin echo difference technique [16], as fully described recently [17,18]. Briefly, to implement
the J-editing technique, a pair of a frequency-selective inversion pulses was inserted into the
standard PRESS method, and then applied on the GABA C-3 resonance at 1.9 ppm on alter-
nate scans, using TE/TR 68/2500ms. This resulted in two subspectra in which the GABA C-4
resonance at 3.03 ppm and Glx C-2 resonance at 3.71 ppm were alternately inverted or not
inverted. Subtracting the two subspectra yielded a spectrum consisting only of the edited
GABA C-4 and Glx C-2 resonances, with all overlapping resonances eliminated. For each
voxel, the data were acquired in 10.1 min using 128 interleaved excitations (256 total), with the
editing pulse on or off. The magnetic field homogeneity for the acquisitions was typically
12Hz, as assessed from the full width at half maximum of the unsuppressed voxel tissue
water resonance.
1H MRS data processing and quantification. Both the short-TE PRESS and J-edited
spectral data were processed according now established methods and then quantified with the
LCModel package (V. 6.2), using a basis set of MR spectra experimentally measured from a
phantom containing GABA, glutamine, glutamate, NAA tCr, tCho, and myo-inositol, with
default LCModel macromolecule (MM) resonances at or near 0.9, 1.2, 1.4, 1.7 and 2.0 ppm.
All the metabolites were quantified as “absolute” concentrations in mmol/L by LCModel using
the unsuppressed water signal in each voxel as a signal intensity and concentration reference,
assuming a water content of 82% [19]. The reliability of the LCModel-derived metabolite levels
Table 1. Participant Characteristics and Demographics.
N Gender(Boy/girl) Age(year) Age(mean±SD)
ACC AS 34 28/6 2–12 5.2±2.0
Control 19 12/7 2–11 5.6±2.6
Left cerebellum AS 23 19/4 4–9 5.1±1.4
Control 12 9/3 2–12 6.5±2.8
AS, Asperger’s syndrome
doi:10.1371/journal.pone.0169288.t001
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was expressed with Cramer-Rao lower bounds (CRLB), with a relative CRLB (%SD) of 20% set
as the upper cutoff limit of acceptable uncertainty for each metabolite. By this standard, no
spectra were rejected due to a high quantification uncertainty.
Statistical analysis
Mean levels of the metabolites of interest were compared between children with AS and con-
trols. In primary analyses, NAA alone was compared between the groups, and in secondary,
exploratory analyses, tCr, tCho, mI, Glx and GABA were compared, without correction for
multiple comparisons. Student’s t-tests were used to assess the differences between AS and
controls, and each group’s gender differences at the significance of p = 0.05 (two-tailed). Pear-
son’s correlation coefficient was used to assess for potential associations between age and
metabolite levels in AS.
Results
Levels of ACC NAA, tCr, tCho, and mI were lower in children with AS than in the controls
(p<0.05). On the other hand, no differences of these metabolites were found in the cerebellum
(Table 2). Furthermore, no significant differences in any of the metabolites were found
between boys and girls either within the AS or within control groups and no significant associ-
ations were found between age and any of the metabolite levels in AS.
Discussion
In this study, we found levels of NAA in the ACC to be significantly lower in children with AS
than in age- and sex-matched control children, while no such difference was found in the cere-
bellum. In secondary analyses, we also found lower levels of tCr, tCho, and mI in the ACC of
children with AS compared to controls, but no differences in the cerebellum. These results are
in disagreement with the results of two prior studies in adults with AS, which reported eleva-
tions of ACC and frontal lobe NAA compared to controls [12,14]. A third prior study had
Fig 1. Positions of the measurement voxel in ACC (anterior cingulate cortex) and left cerebellum and
representative spectra from each voxel. (LEFT) Positions of the measurement voxel in the anterior
cingulate cortex (ACC) and left cerebellum. (RIGHT) Representative short TE and J-edited spectra obtained.
doi:10.1371/journal.pone.0169288.g001
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measured levels of metabolites in amygdala-hippocampal complex in 10–50 years old AS, and
found no significant difference compared to controls although it reported report a significant
age-related reduction in NAA, NAA/Cr, and tCho in the AS group [13], suggesting potential
differences in these metabolites between adults and children (vide infra). With respect to the
levels of the other metabolites, one of the prior studies, reported elevations of prefrontal tCr
and tCho [12], which were also in disagreement with the results of the present study.
While the reason for the discrepancy between the present results of decreased ACC and fron-
tal neurometabolites in AS and prior studies that reported elevations of the same metabolites in
similar brain regions could be methodological or due to differences in AS cohort characteristics,
the difference in age may be the primary reason for the discrepancy: in the present study we
have investigated only children with AS where prior studies had investigated only adults [12,13]
or a mixture of children and adults [14]. In fact, to our knowledge, the present study is the first
to use 1H MRS to assess the neurometabolic characteristics of children with AS, and age-depen-
dent metabolic differences have been reported, albeit in different regions [10, 13].
Interestingly, a meta-analysis of 1H MRS data in ASD, which included AS, had found NAA
to be decreased specifically in whole-brain gray and while matter in children [10]. In addition,
and importantly, the meta-analysis showed age-dependent changes in parietal cortex, the cere-
bellum, and the anterior cingulate cortex [10]. These findings suggest metabolite levels in AS
may fluctuate with age, although we found no significant association between age and levels of
any of the metabolites, likely due to the limited age range and sample size of this study.
The involvement of the ACC in the executive function neuronal network and its role in the
cognitive control attention are well established [20,21]. In addition, the ACC has close ana-
tomic connections to the amygdala and the orbitofrontal cortex, which are participants in
emotional expression. In non-human primates, experimentally-induced ACC lesions lead to
poor vocal and facial expression, with tendency toward isolation from and poor communica-
tion with other primates in the colony [22]. In humans, likewise, injury to the ACC leads to
decreased social interactions and increased isolation, and decreased verbal communication,
although with increased tendency to interact with and manipulate inanimate objects [22]. Our
finding of decreased ACC NAA in children with AS is consistent with abnormal ACC function
in the disorder.
The meta-analysis of 1H MRS studies in ASD suggested a strong association between the
degree of NAA abnormalities and developmental changes, especially in frontal lobe. ASD chil-
dren with larger-than-normal brain size also had lower-than-normal NAA levels, suggesting
that early increase in brain size in children with ASD may occur through an increase in non-
neuron tissues, such as glial cell proliferation [10].
Table 2. Metabolite concentrations (mmol/L).
NAA tCr tCho mI Glx GABA
ACC AS(n = 34) 5.6±0.8* 4.6±0.7** 1.2±0.2* 3.5±0.9** 9.1±2.1 0.7±0.3
control(n = 19) 6.0±0.8 5.2±0.9 1.3±0.3 4.3±1.0 10.0±3.1 0.9±0.4
Left cerebellum AS(n = 23) 5.9±0.8 5.7±1.1 1.3±0.5 4.1±0.7 8.5±1.5 1.5±0.5
control(n = 12) 6.1±0.9 5.9±1.0 1.4±0.5 4.6±1.7 8.0±1.6 1.5±0.6
Values are the mean±SD.
*p<0.05;
**p<0.01
ACC anterior cingulate cortex, AS, Asperger’s syndrome. NAA, N-acetylaspartate; tCr, creatine/phosphocreatine; tCho, choline-containing compounds; mI,
myo-Inositol; Glu, glutamate; Gln, Glutamin; Glx, Glu+Gln. GABA, gamma-aminobutyric acid.
doi:10.1371/journal.pone.0169288.t002
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As with the levels of NAA, we found levels of tCr, tCho and mI levels to be significantly
lower in the ACC in children with AS than in controls, but not in the cerebellum. This selective
reduction in metabolite levels in the ACC region but not in the cerebellum strongly suggests a
decrease in the density and/or function of neuronal and glia cells density in the ACC of chil-
dren with AS. Such cellular abnormalities in a key brain regulatory structure can plausibly con-
tribute to difficulty in modulating emotional reactivity that characterizes children with AS and
ASD.
This study has two of notable limitations. First, the sample size was relatively small and clin-
ical records for several patients were incomplete, which limited statistical power and the ability
to detect potential associations between clinical variables, including AS severity scores, and
demographic variables vs. metabolite levels. Second, we did not obtain volumetric MR images
to assess potential tissue volume differences and to correct the metabolite levels for tissue het-
erogeneity within the voxels of interest. However, no abnormal signal or atrophy was detected
in the brain of AS or controls. The findings of this study should therefore be interpreted taking
into consideration these caveats.
In summary, this study has found that NAA and the other major brain metabolites detect-
able by 1H MRS are significantly lower in the ACC of children with AS than in matched
healthy controls, which provides additional evidence implicating ACC is implicated in the
pathophysiology of AS. If replicated, the results of this study could lead to the development of
1H MRS as a noninvasive technique for characterizing metabolic abnormalities in children
with AS that could serve as diagnostic and therapeutic response biomarkers for the disorder.
Supporting Information
S1 Dataset. The file summarizes all the relevant data that have been used in the statistical
analyses.
(XLSX)
Acknowledgments
We wish to thank Dr. Dikoma Shungu of Weill Cornell Medicine for useful discussion on the
MRS methodology and for critically evaluating of our manuscript.
Author Contributions
Conceptualization: AG HI.
Data curation: AG HI SH MH.
Formal analysis: AG.
Funding acquisition: KM MH SK.
Investigation: AG HI MH SH YT TM YA MM.
Methodology: KM.
Project administration: SK.
Resources: AG HI YT TM KM YA.
Supervision: MH SK.
Validation: HI.
MRS Study of ACC in Asperger’s Syndrome
PLOS ONE | DOI:10.1371/journal.pone.0169288 January 6, 2017 6 / 8
Writing – original draft: AG.
Writing – review & editing: AG HI.
References
1. American Psychiatric Association. (2000) Diagnostic and statistical manual of mental disorders. Fourth
Edition-Text Revision. Washington DC: American Psychiatric Publishing.
2. American Psychiatric Association. (2013) Diagnostic and Statistical Manual of Mental Disorders. fifth
Edition. Washington DC: American Psychiatric Publishing.
3. Yu KK, Cheung C, Chua SE, McAlonan GM. Can Asperger syndrome be distinguished from autism? An
anatomic likelihood meta-analysis of MRI studies. J Psychiatry Neurosci. 2011; 36:412–21. doi: 10.
1503/jpn.100138 PMID: 21406158
4. Dora P, Tomisiav J, Maja C, Patrick RH, Goran S. Recent developments in neuropathology of autism
spectrum disorders. Transl Neurosci. 2011; 2:256–64. PMID: 22180840
5. Bush G, Luu P, Posner MI. Cognitive and emotional influences in anterior cingulate cortex. Trends
Cogn. 2000; 4:215–222.
6. Kennedy DP, Courchesne E. Functuinal abnormallyties of the default network during self-and other-
reflection in autism. Soc Cogn Affect Neurosci. 2008; 3:177–90. doi: 10.1093/scan/nsn011 PMID:
19015108
7. Agm Y, Joseph RM, Barton JJ, Manoach DS. Reduced cognitive control of response inhibition by the
anterior cingulate cortex in autism spectrum disorders. Neuroimage. 2010; 52:336–47. doi: 10.1016/j.
neuroimage.2010.04.010 PMID: 20394829
8. Kana RK, Keller TA, Minshew NJ, Just MA. Inhibitory control in high-functioning autism: decreased acti-
vation and underconnectivity in inhibition networks. Biol Psychiatry. 2007; 62:198–206. doi: 10.1016/j.
biopsych.2006.08.004 PMID: 17137558
9. Gomot M, Bernard FA, Davis MH, Belmote MK, Ashwin C, Bullmore ET, et al. Change detection in chil-
dren with autism: an auditory event-related fMRI study. Neuroimage 2006; 29:475–84. doi: 10.1016/j.
neuroimage.2005.07.027 PMID: 16115783
10. Aoki Y, Kasai K, Yamasue H. Age-related change in brain metabolite abnormallyties in autism: a meta-
analysis of proton magnetic resonance spectroscopy studies. Transl Psychiatry. 2012; 2:e69. doi: 10.
1038/tp.2011.65 PMID: 22832731
11. Ipser JC, Syal S, Bentley J, Adnams CM, Steyn B,Stein DJ. 1H-MRS in autism spectrum disorders:
asystematic meta-analysis. Metab Brain Dis. 2012; 27:275–87. doi: 10.1007/s11011-012-9293-y PMID:
22426803
12. Murphy D.G, Critchley H.D, Schmitz N, McAlonan G, Amelsvoort T, Robertoson D, et al. Asperger Syn-
drome: A proton Magnetic Resonance Spectroscopy Study of Brain. Arch Gen Psychiatry. 2002;
59:885–91. PMID: 12365875
13. Oner O, Devrimci-Ozguven H, Oktem F, Yagmurlu B, Baskak B, Munir KM. Proton MR spectroscopy:
higher right anterior cingulate N-acetylasparate/choline ratio in Asperger syndrome compared with
healthy controls. AJNR Am J Neuroradiol. 2007; 20:1494–8.
14. O’Brien FM, Page L, O’Gorman RL, Bolton P, Sharma A, Baird G. Maturation of limbic regions in Asper-
ger syndrome: A prelim study using proton magnetic resonance spectroscopy and structural magnetic
resonance imaging. Psychiatry Research Neuroimaging. 2010; 184:77–85. doi: 10.1016/j.pscychresns.
2010.08.007 PMID: 20952166
15. Cote CJ, Wilson S. Guideline for monitoring and management of pediatric patients during and after
sedation for diagnostic and therapeutic procedures: an update. Pediatrics. 2006; 118:2587–602. doi:
10.1542/peds.2006-2780 PMID: 17142550
16. Rorthman DL, Petroff OAC, Behar KL, Mattson RH. Localised 1H NMR measurements of γ-aminobu-
tyric acid in human. Neurology. 1993; 90:5662–6.
17. Geramita M, van der Veen JW, Barnett AS, Savostyanova AA, Shen J, Weinberger DR, et al. Repro-
ducibility of prefrontal gamma-aminobutyric acid measurements with J-edited spectroscopy. NMR
Biomed. 2011; 24:1089–98. doi: 10.1002/nbm.1662 PMID: 21290458
18. Shungu DC, Mao X, Gonzales R, Soones TN, Dyke JP, van der Veen JW, et al. Brain γ-aminobutyric
acid (GABA) detection in vivo with the J-editing (1) H MRS technique: a comprehensive methodological
evaluation of sensitivity enhancement, macromolecule contamination and test-retest reliability. NMR
Biomed. 2016; 29(7):932–42. doi: 10.1002/nbm.3539 PMID: 27173449
19. Harada M, Miyoshi H, Uno M, Okada T, Hisaoka S, Hori A, et al. Neuronal impairment of adult moya-
moya disease detected by quantified proton MRS and comparison with cerebral perfusion by SPECT
MRS Study of ACC in Asperger’s Syndrome
PLOS ONE | DOI:10.1371/journal.pone.0169288 January 6, 2017 7 / 8
with Tc-99m HM-PAO: A trial of clinical quantification of metabolites. Journal of Magnetic Resonance
Imaging. 1999; 10:124–29. PMID: 10441014
20. Osaka N, Osaka M, Kondo H, Morishita M, Fukuyama H, Shibasaki H. The neural basis of executive
function in working memory: Am fMRI study based on individual differences. Neuroimage. 2004;
21:623–31. doi: 10.1016/j.neuroimage.2003.09.069 PMID: 14980565
21. Cohen JD, Botvinick M, Carter CS. Anterior cingulated and prefrontal cortex: who’s in control? Nat Neu-
rosci. 2000; 3:421–23. doi: 10.1038/74783 PMID: 10769376
22. Hadland KA, Rushworth MF, Gafffan D, Passingham RE. The effect of cingulate lesions on social
behavior and emotion. Neuropsychologia. 2003; 41:919–31. PMID: 12667528
MRS Study of ACC in Asperger’s Syndrome
PLOS ONE | DOI:10.1371/journal.pone.0169288 January 6, 2017 8 / 8
